In January 2025, the US Food and Drug Administration (FDA) authorized the marketing of nicotine pouches to individuals aged 21 years and older. However, the use of nicotine pouches among teens appears ...

A drug investigation is underway after a welfare check at Point Tobacco & Vape in Collinsville Tuesday, July 1, according to the Henry County Sheriff’s Office.

When John,* 43, first heard about Zyn from a friend a couple years ago, it struck him as a “much better alternative to ...

Consumer Advocates for Smoke Free Alternatives Association will end its active advocacy in August due to lack of funds.

E-cigarettes have become increasingly popular over the last two decades, especially among young people. These sleek, ...

Turns out the disposable nicotine delivery systems are, as suspected, worse than the real thing, according to a new study ...

Achieve Life Sciences is partnering with marketing company Omnicom to lead Achieve's commercial launch of a potential new treatment for nicotine dependence in the U.S. The pharmaceutical company on ...

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved ...

The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent HIV, the creator of the drug, Gilead Sciences, announced on Wednesday.

Gilead officials lauded the FDA's approval of lenacapavir, which has been studied and developed over nearly two decades. "We now have a very real opportunity to end the HIV epidemic," said Daniel ...

For the new program, the FDA will issue a limited number of “national priority vouchers” to companies “aligned with U.S. national priorities,” the agency said in a statement.

Final analysis included 63 studies, with 39 on OCD and 24 on nicotine, involving 2,998 individuals (mean age = 38.6 years; 44.9% women; 31.4% Black).